(Q34617851)

3 August 2017

title

Obesity and mortality in men with locally advanced prostate cancer: analysis of RTOG 85-31. (English)

1 reference

3 August 2017

0 references

1 reference

Jason A Efstathiou

1

1 reference

3 August 2017

Kyounghwa Bae

2

1 reference

3 August 2017

William U Shipley

3

1 reference

3 August 2017

Gerald E Hanks

4

1 reference

3 August 2017

Miljenko V Pilepich

5

1 reference

3 August 2017

Howard M Sandler

6

1 reference

3 August 2017

Matthew R Smith

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

110

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

2691-2699

1 reference

3 August 2017

cites work

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Body-mass index and mortality in Korean men and women.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Prevalence of overweight and obesity in the United States, 1999-2004

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Body weight and mortality among men and women in China

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Excess deaths associated with underweight, overweight, and obesity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Changes in body composition during hormonal therapy for prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Role of the insulin-like growth factor family in cancer development and progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Diet, obesity, and risk of fatal prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Evaluation of survival data and two new rank order statistics arising in its consideration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

The randomization and stratification of patients to clinical trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy

7 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Influence of body mass index on biochemical outcome after permanent prostate brachytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Testosterone and estradiol among older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Effect of obesity and body fat distribution on sex hormones and insulin in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Leptin influences cellular differentiation and progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Insulin sensitivity during combined androgen blockade for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Body mass index and risk of prostate cancer in U.S. health professionals

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Changes in body composition during androgen deprivation therapy for prostate cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3047389

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

26 October 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23093

A comparison of four patient immobilization devices in the treatment of prostate cancer patients with three dimensional conformal radiotherapy

21 January 2018

1 reference

12 December 2020

Obesity and survival after radical prostatectomy: A 10-year prospective cohort study

1 reference

12 December 2020

Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer

1 reference

12 December 2020

Does Body Mass Index Affect Preoperative Prostate Specific Antigen Velocity or Pathological Outcomes After Radical Prostatectomy?

1 reference

12 December 2020

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

1 reference

12 December 2020

Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center

1 reference

12 December 2020

Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.23093

1 reference

3 August 2017

1 reference

3 August 2017

1 reference